Ameritas Investment Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.8K | Buy |
15,456
+2,832
| +22% | +$8.75K | ﹤0.01% | 2211 |
|
|
2025
Q1 | $44.1K | Hold |
12,624
| – | – | ﹤0.01% | 2175 |
|
|
2024
Q4 | $41.3K | Hold |
12,624
| – | – | ﹤0.01% | 2299 |
|
|
2024
Q3 | $48.6K | Hold |
12,624
| – | – | ﹤0.01% | 2208 |
|
|
2024
Q2 | $39K | Buy |
12,624
+3,500
| +38% | +$10.8K | ﹤0.01% | 2275 |
|
|
2024
Q1 | $23.5K | Hold |
9,124
| – | – | ﹤0.01% | 2493 |
|
|
2023
Q4 | $22.8K | Hold |
9,124
| – | – | ﹤0.01% | 2527 |
|
|
2023
Q3 | $18.5K | Hold |
9,124
| – | – | ﹤0.01% | 2570 |
|
|
2023
Q2 | $21K | Hold |
9,124
| – | – | ﹤0.01% | 2543 |
|
|
2023
Q1 | $27.6K | Buy |
9,124
+3,000
| +49% | +$9.09K | ﹤0.01% | 2326 |
|
|
2022
Q4 | $16.9K | Hold |
6,124
| – | – | ﹤0.01% | 2635 |
|
|
2022
Q3 | $11K | Hold |
6,124
| – | – | ﹤0.01% | 2764 |
|
|
2022
Q2 | $16K | Hold |
6,124
| – | – | ﹤0.01% | 2643 |
|
|
2022
Q1 | $18K | Hold |
6,124
| – | – | ﹤0.01% | 2597 |
|
|
2021
Q4 | $24K | Hold |
6,124
| – | – | ﹤0.01% | 2549 |
|
|
2021
Q3 | $26K | Hold |
6,124
| – | – | ﹤0.01% | 2550 |
|
|
2021
Q2 | $19K | Buy |
+6,124
| New | +$19K | ﹤0.01% | 2751 |
|
|
2019
Q2 | – | Sell |
-2,944
| Closed | -$11K | – | 3045 |
|
|
2019
Q1 | $11K | Hold |
2,944
| – | – | ﹤0.01% | 2654 |
|
|
2018
Q4 | $11K | Hold |
2,944
| – | – | ﹤0.01% | 2620 |
|
|
2018
Q3 | $28K | Hold |
2,944
| – | – | ﹤0.01% | 2324 |
|
|
2018
Q2 | $21K | Buy |
+2,944
| New | +$21K | ﹤0.01% | 2476 |
|